We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BBC market cap is 9.54M. The company's latest EPS is USD 11.3825 and P/E is 2.10.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 October 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 146k | 114k | 50k | 132k | 79k |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 11.39M | 5.55M | -14.99M | -4.06M | 4.55M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 October 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40.71M | 38.74M | 19.58M | 8.69M | 12.08M |
| Total Liabilities | 3.7M | 3.25M | 1.46M | 653k | 762k |
| Total Equity | 37.02M | 35.49M | 18.12M | 8.04M | 11.32M |
| Market Cap | 9.54M |
| Price to Earnings Ratio | 2.10 |
| Price to Sales Ratio | 120.81 |
| Price to Cash Ratio | 43.78 |
| Price to Book Ratio | 0.84 |
| Dividend Yield | - |
| Shares Outstanding | 400k |
| Average Volume (1 week) | 2.53k |
| Average Volume (1 Month) | 3.36k |
| 52 Week Change | -7.77% |
| 52 Week High | 31.99 |
| 52 Week Low | 21.41 |
| Spread (Intraday) | 0.02 (0.08%) |
| Company Name | Virtus LifeSci Biotech Clinical Trials ETF |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
